Correlation Between NRBO Old and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both NRBO Old and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NRBO Old and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NRBO Old and Virax Biolabs Group, you can compare the effects of market volatilities on NRBO Old and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NRBO Old with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of NRBO Old and Virax Biolabs.
Diversification Opportunities for NRBO Old and Virax Biolabs
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between NRBO and Virax is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding NRBO Old and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and NRBO Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NRBO Old are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of NRBO Old i.e., NRBO Old and Virax Biolabs go up and down completely randomly.
Pair Corralation between NRBO Old and Virax Biolabs
Given the investment horizon of 90 days NRBO Old is expected to generate 0.77 times more return on investment than Virax Biolabs. However, NRBO Old is 1.29 times less risky than Virax Biolabs. It trades about -0.02 of its potential returns per unit of risk. Virax Biolabs Group is currently generating about -0.09 per unit of risk. If you would invest 198.00 in NRBO Old on December 29, 2024 and sell it today you would lose (9.00) from holding NRBO Old or give up 4.55% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 34.43% |
Values | Daily Returns |
NRBO Old vs. Virax Biolabs Group
Performance |
Timeline |
NRBO Old |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Virax Biolabs Group |
NRBO Old and Virax Biolabs Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with NRBO Old and Virax Biolabs
The main advantage of trading using opposite NRBO Old and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NRBO Old position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.NRBO Old vs. Allarity Therapeutics | NRBO Old vs. Virax Biolabs Group | NRBO Old vs. Quoin Pharmaceuticals Ltd | NRBO Old vs. Biodexa Pharmaceticals |
Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
CEOs Directory Screen CEOs from public companies around the world |